SB

Director Director DIN 07598351
DIN 07598351 First appointment Sep 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2016
Shareholding value •••• Premium profile

About Suja Babu

Data last updated:

Suja Babu was a Director at Lifio Bio-Science India Private Limited (2016–2021) and Director at Pure Em Life Science India Private Limited (2019–2020). The companies operate in Trading and Pharma.

DIN 07598351
Primary Designation Director
Industry Trading
First Appointment 27 Sep 2016

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Sep 20162016₹5.2 Lakh (FY 2022)Active
Director24 Jul 20192019₹8.43 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lifio Bio-Science India Private Limited
Pure Em Life Science India Private Limited
Premium access

Shareholding and investment profile for Suja Babu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suja Babu

Suja Babu was first appointed on 27 Sep 2016 as Director at Lifio Bio-Science India Private Limited. The most recent appointment on record is 24 Jul 2019 at Pure Em Life Science India Private Limited.

Suja Babu held 2 earlier board appointments: Lifio Bio-Science India Private Limited (Director, 27 Sep 2016 to 10 Mar 2021); Pure Em Life Science India Private Limited (Director, 24 Jul 2019 to 15 Oct 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available